论文部分内容阅读
健择（gemcitabine）是治疗胰腺癌、非小细胞肺癌（NSCLC）的一种新型抗癌药，我国文献报道尚少，我们采用健择联合顺铂治疗２６例晚期非小细胞肺癌，并与异环磷酰胺联合顺铂及表阿霉素方案进行对比，现将结果报道如下。１临床资料与方法１．１病例选择５２例晚期非小细胞肺癌
Gemcitabine is a new type of anticancer drug for the treatment of pancreatic cancer and non-small cell lung cancer (NSCLC). Although there are few reports in our country, we treated 26 cases of advanced non-small cell lung cancer with gemcitabine and cisplatin, Cyclophosphamide combined with cisplatin and epirubicin programs are compared, the results reported below. 1 Clinical data and methods 1.1 Case Selection 52 cases of advanced non-small cell lung cancer